when administered systemically , ptx inhibits the dhfr-dependent conversion of sepiapterin or 7,8-dihydrobiopterin ( bh2 ) to tetrahydrobiopterin ( bh4 ) , demonstrating that ptx enters brain at pharmacologically relevant concentrations .
C0006104
brain
C0086045
concentrations